Manual color monitoring to optimize hematopoietic progenitor cell collection on the Fenwal Amicus.
about
Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy.Discordant CD34+ cell results in peripheral blood and hematopoietic progenitor cell-apheresis product: implications for clinical decisions and impact on patient treatment.First comparative evaluation of a new leukapheresis technology in non-cytokine-stimulated donors.
P2860
Manual color monitoring to optimize hematopoietic progenitor cell collection on the Fenwal Amicus.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Manual color monitoring to opt ...... llection on the Fenwal Amicus.
@en
Manual color monitoring to opt ...... llection on the Fenwal Amicus.
@nl
type
label
Manual color monitoring to opt ...... llection on the Fenwal Amicus.
@en
Manual color monitoring to opt ...... llection on the Fenwal Amicus.
@nl
prefLabel
Manual color monitoring to opt ...... llection on the Fenwal Amicus.
@en
Manual color monitoring to opt ...... llection on the Fenwal Amicus.
@nl
P2860
P356
P1476
Manual color monitoring to opt ...... llection on the Fenwal Amicus.
@en
P2093
Edwin A Burgstaler
P2860
P304
P356
10.1002/JCA.20280
P577
2011-01-25T00:00:00Z